Kingworld Medicines Group Limited (1110.HK) HKSE

Currency In HKD

AD

Valuation

Market Cap273.77M
Enterprise Value443.3M
P/E Ratio17.87
PEG Ratio0.2
Price/Sales Ratio0.25
Price/Book Ratio0.33
Enterprise/Revenue0.58
Enterprise/EBITDA6.11

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.01
Operating Margin0.09
AD

Management Effectiveness

Return On Assets0.01
Return On Equity0.02

Income Statement

Revenue917.34M
Revenue/Share1.35
Gross Profit247.91M
EBITDA72.03M
Net Income11.28M
Diluted EPS0.02

Balance Sheet

Total Cash188.35M
Total Cash/Share0.32
Total Debt438.04M
Total Debt/Equity0.73
Current Ratio1.05
Book Value Per Share1.12

Price History

52-Week Change-22.55
52-Week High0.78
52-Week Low0.33
Moving Average 50 Days0.42
Moving Average 200 Days0.46

Statistics

Average Volume2.43M
Shares Outstanding589.81M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio1.58
Last Split FactorN/A
Last Split DateN/A
AD